{"id":"NCT01170663","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma","officialTitle":"A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-12","primaryCompletion":"2013-07","completion":"2017-02","firstPosted":"2010-07-27","resultsPosted":"2014-07-31","lastUpdate":"2019-09-18"},"enrollment":665,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"Ramucirumab (IMC-1211B) DP","otherNames":["LY3009806","IMC-1211B"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]}],"arms":[{"label":"Ramucirumab (IMC-1211B) Drug Product (DP) and Paclitaxel","type":"EXPERIMENTAL"},{"label":"Placebo and Paclitaxel","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase III randomized multicenter double-blind, placebo controlled trial evaluating the safety and efficacy of paclitaxel plus ramucirumab (IMC-1211B) drug product (DP) compared to paclitaxel plus placebo.","primaryOutcome":{"measure":"Overall Survival Time (OS)","timeFrame":"Randomization up to 27.5 months","effectByArm":[{"arm":"Ramucirumab (IMC-1211B) Plus Paclitaxel","deltaMin":9.6,"sd":null},{"arm":"Placebo Plus Paclitaxel","deltaMin":7.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0169"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":167,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Chile","Estonia","France","Germany","Hungary","Israel","Italy","Japan","Lithuania","Mexico","Poland","Portugal","Romania","Russia","Singapore","South Korea","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["37129153","34795131","33355909","33274542","31234645","30557792","28716815","26747859","26510663","25240821"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":161,"n":327},"commonTop":["Neutropenia","Decreased appetite","Alopecia","Fatigue","Anaemia"]}}